Evidence Requirements for DTx vs Drugs

Due to the lack of industry-wide frameworks for DTx evidence, payers' requirements are usually the same as drugs. However, drugs and DTx are very different in nature, and it is often hard to fit DTx into the traditional evidence standards. Even when DTx solutions have proven effective and safe, some payers have refused to continue covering them (for example, Aetna news). This aligns with a point raised in many HealthXL meetings; payers are sometimes more demanding with DTx compared to drugs due to the novelty of these therapies and the lack of knowledge, making it harder for DTx companies to get buy-in. Join this meeting to have a peer-to-peer conversation about: